查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760555

2025年全球人類偏肺病毒診斷市場報告

Human Metapneumovirus Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計人類偏肺病毒診斷市場規模將在未來幾年內快速成長。到2029年，該市場規模將達到7.9億美元，複合年成長率為10.1%。預測期內的預期成長動力包括：對早期準確呼吸道感染疾病診斷的需求不斷成長、對照護現場解決方案的投資不斷增加、新興市場醫療保健涵蓋範圍的擴大、全球對疫情防控的關注，以及多重呼吸道檢測試劑盒的日益整合。預測期內的主要趨勢包括：自動化和高通量診斷系統的開發、向分散式診斷模型的轉變、人工智慧在診斷解讀中的應用、家用檢測套組的普及以及公共和私人公司之間合作的不斷加強。

呼吸道感染疾病的增加預計將推動人類偏肺病毒診斷市場的成長。由病毒、細菌和其他病原體引起的呼吸道感染疾病會影響呼吸系統，包括鼻竇、喉嚨、氣道和肺部。盛行率的上升被認為與接觸有害污染物有關，這些污染物會刺激和削弱呼吸道，使人們更容易受到感染疾病。人類偏肺病毒診斷可以辨識出呼吸道感染疾病的病因，進而達到精準治療和更佳管理。例如，英國衛生安全局於2025年1月報告稱，在2023-2024年疫情季節，英格蘭的呼吸道感染率將在2023年第50周和第52週達到峰值，每10萬人感染8例，並將在2024年第4週進一步上升至每10萬人感染10.2例，封閉迴路境中的急性感染疾病呼吸道感染疾病疫情的日益普及正刺激人類亞肺病毒診斷市場的擴張。

人類偏肺病毒診斷市場的主要企業正致力於開發創新解決方案，例如呼吸道聚合酵素鏈鎖反應(PCR) 診斷工具，以增強其分子診斷能力，從而檢測多種呼吸道病原體。呼吸道 PCR 診斷解決方案是一種分子檢測方法，用於擴增、檢測和鑑定呼吸道病原體的遺傳物質，具有高靈敏度和特異性。例如，2023 年 3 月，中國分子診斷公司江蘇百奧菲特斯科技有限公司推出了呼吸道病原體多重即時PCR診斷套件。此解決方案旨在快速、高精度地同時檢測多種呼吸道病原體，並提高臨床和照護現場的診斷效率。其廣泛的覆蓋範圍和準確的性能極大地幫助了及時的臨床決策，特別是在管理具有重疊症狀的呼吸道感染疾病方面。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人類偏肺病毒診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球人類偏肺病毒診斷市場：成長率分析
  • 全球人類偏肺病毒診斷市場表現：規模與成長，2019-2024 年
  • 全球人類偏肺病毒診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球人類偏肺病毒診斷總目標市場（TAM）

第6章市場區隔

  • 全球人類偏肺病毒診斷市場（依產品類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 試劑和套件
  • 裝置
  • 全球人類偏肺病毒診斷市場（按檢測類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 免疫診斷
  • 基於文化的方法
  • 其他測試類型
  • 全球人類偏肺病毒診斷市場（技術、效能與預測），2019-2024 年、2024-2029 年、2034 年
  • 基於PCR的診斷
  • 次世代定序（NGS）
  • 螢光試驗
  • 橫向流動化驗
  • 微陣列技術
  • 其他先進技術
  • 全球人類偏肺病毒診斷市場（依最終用途、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷與參考實驗室
  • 學術研究所
  • 其他最終用戶
  • 全球人類偏肺病毒診斷市場，按試劑和套件類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 樣本採集套件
  • 核酸萃取試劑套件
  • 病毒運輸介質
  • 對照試劑
  • 全球人類偏肺病毒診斷市場，按設備類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素連鎖反應熱迴圈儀
  • 自動分析儀
  • 核酸萃取裝置
  • 螢光讀數儀

第7章 區域和國家分析

  • 全球人類偏肺病毒診斷市場（按地區、績效及預測）2019-2024、2024-2029、2034
  • 全球人類偏肺病毒診斷市場（依國家/地區、績效及預測）2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 人類偏肺病毒診斷市場：競爭格局
  • 人類偏肺病毒診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc.
  • ARUP Laboratories
  • Qiagen NV
  • Diasorin
  • Luminex Corporation
  • bioMerieux
  • Seegene Inc.
  • Cepheid
  • R-Biopharm AG
  • Certest Biotec
  • ZeptoMetrix
  • Xi'an Tianlong Science and Technology Co. Ltd
  • The Native Antigen Company
  • Hangzhou Testsea Biotechnology Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年人類偏肺病毒診斷市場：提供新機會的國家
  • 2029年人類偏肺病毒診斷市場：細分市場帶來新機會
  • 2029年人類偏肺病毒診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35432

Human metapneumovirus (hMPV) diagnostics involve the methods and criteria used to detect and confirm infection with human metapneumovirus, a respiratory pathogen that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in children, the elderly, and immunocompromised individuals.

The primary product types in human metapneumovirus diagnostics are reagents and kits, as well as instruments. Reagents and kits are essential laboratory products that contain chemical substances and tools for performing specific diagnostic tests or experiments. The diagnostic test types include molecular diagnostics, immunodiagnostics, culture-based methods, and others, utilizing technologies such as PCR-based diagnostics, next-generation sequencing (NGS), immunofluorescence assays, lateral flow assays, microarray technology, and others. These tests are used in various settings, including hospitals and clinics, diagnostic and reference laboratories, academic and research institutions, among others.

The human metapneumovirus diagnostics market research report is one of a series of new reports from The Business Research Company that provides human metapneumovirus diagnostics market statistics, including human metapneumovirus diagnostics industry global market size, regional shares, competitors with a human metapneumovirus diagnostics market share, detailed human metapneumovirus diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the human metapneumovirus diagnostics industry. This human metapneumovirus diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human metapneumovirus diagnostics market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to an increase in pediatric hospitalization rates due to respiratory infections, heightened awareness of viral respiratory pathogens, the initial adoption of molecular diagnostic tools, the expansion of public health surveillance programs, and greater funding for pediatric respiratory diseases.

The human metapneumovirus diagnostics market size is expected to see rapid growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by rising demand for early and accurate respiratory infection diagnostics, growing investments in point-of-care diagnostic solutions, expanding healthcare access in emerging markets, a global focus on pandemic preparedness, and greater integration of multiplex respiratory panels. Key trends in the forecast period include the development of automated and high-throughput diagnostic systems, a shift toward decentralized diagnostic models, the use of artificial intelligence in diagnostic interpretation, the increasing adoption of at-home testing kits, and growing collaboration between public and private diagnostic companies.

The increasing prevalence of respiratory infections is expected to drive growth in the human metapneumovirus diagnostics market. Respiratory infections, caused by viruses, bacteria, or other pathogens, affect the respiratory system, including the sinuses, throat, airways, and lungs. The rising prevalence can be linked to the exposure to harmful pollutants that irritate and weaken the respiratory tract, making it more susceptible to infections. Human metapneumovirus diagnostics help identify hMPV as the cause of respiratory infections, allowing for accurate treatment and better management. For example, in January 2025, the UK Health Security Agency reported that during the 2023-2024 season, respiratory infection rates in England peaked at 8.0 per 100,000 in weeks 50 and 52 of 2023, and rose further to 10.2 per 100,000 in week 4 of 2024, while acute respiratory infection incidents in closed settings reached 2,051, with most cases reported in care homes and hospitals. This growing prevalence of respiratory infections is fueling the expansion of the human metapneumovirus diagnostics market.

Leading companies in the human metapneumovirus diagnostics market are focusing on developing innovative solutions, such as respiratory polymerase chain reaction (PCR) diagnostic tools, to enhance molecular diagnostic capabilities for detecting a wide range of respiratory pathogens. A respiratory PCR diagnostic solution is a molecular testing method used to detect and identify respiratory pathogens by amplifying their genetic material with high sensitivity and specificity. For example, in March 2023, Jiangsu BioPerfectus Technologies Co., Ltd., a molecular diagnostic company based in China, launched its respiratory pathogen multiplex real-time PCR diagnostic kit. This solution is designed to simultaneously detect multiple respiratory pathogens with high accuracy and a rapid turnaround time, improving diagnostic efficiency in clinical and point-of-care settings. Its broad coverage and precise performance significantly aid timely clinical decision-making, particularly for managing respiratory infections with overlapping symptoms.

In February 2024, AstraZeneca plc, a pharmaceutical company based in the UK, acquired Icosavax Inc. for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its late-stage pipeline and expand its expertise in vaccines for respiratory conditions with high burdens, specifically advancing Icosavax's lead investigational combination vaccine candidate, IVX-A12, which targets both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax Inc., a biotechnology company based in the US, focuses on developing vaccines, especially combination vaccines targeting respiratory viruses such as RSV and hMPV.

Major players in the human metapneumovirus diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ARUP Laboratories, Qiagen NV, Diasorin, Luminex Corporation, bioMerieux, Seegene Inc., Cepheid, R-Biopharm AG, Certest Biotec, ZeptoMetrix, Xi'an Tianlong Science and Technology Co. Ltd, The Native Antigen Company, Hangzhou Testsea Biotechnology Co. Ltd., and Attogene.

North America was the largest region in the human metapneumovirus diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human metapneumovirus diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human metapneumovirus diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human metapneumovirus diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, clinical laboratory services, point-of-care testing services, home sample collection services, public health surveillance services, and contract research and testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human metapneumovirus diagnostics market also includes sales of sample collection devices, diagnostic data management tools, test validation kits, and safety and waste disposal systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Metapneumovirus Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human metapneumovirus diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human metapneumovirus diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human metapneumovirus diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Reagents And Kits; Instruments
  • 2) By Test Type: Molecular Diagnostics; Immunodiagnostics; Culture Based Methods; Other Test Types
  • 3) By Technology: PCR-Based Diagnostics; Next-Generation Sequencing (NGS); Immunofluorescence Assays; Lateral Flow Assays; Microarray Technology; Other Advanced Technologies
  • 4) By End-Use: Hospitals And Clinics; Diagnostic And Reference Laboratories; Academic And Research Institutions; Other End Users
  • Subsegments:
  • 1) By Reagents And Kits: Sample Collection Kits; Nucleic Acid Extraction Kits; Viral Transport Media; Control Reagents
  • 2) By Instruments: Thermal Cyclers; Automated Analyzers; Nucleic Acid Extractors; Fluorescence Readers
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quest Diagnostics; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Metapneumovirus Diagnostics Market Characteristics

3. Human Metapneumovirus Diagnostics Market Trends And Strategies

4. Human Metapneumovirus Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Metapneumovirus Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Human Metapneumovirus Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Human Metapneumovirus Diagnostics Market Growth Rate Analysis
  • 5.4. Global Human Metapneumovirus Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Human Metapneumovirus Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Human Metapneumovirus Diagnostics Total Addressable Market (TAM)

6. Human Metapneumovirus Diagnostics Market Segmentation

  • 6.1. Global Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Instruments
  • 6.2. Global Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunodiagnostics
  • Culture Based Methods
  • Other Test Types
  • 6.3. Global Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR-Based Diagnostics
  • Next-Generation Sequencing (NGS)
  • Immunofluorescence Assays
  • Lateral Flow Assays
  • Microarray Technology
  • Other Advanced Technologies
  • 6.4. Global Human Metapneumovirus Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic And Reference Laboratories
  • Academic And Research Institutions
  • Other End Users
  • 6.5. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Collection Kits
  • Nucleic Acid Extraction Kits
  • Viral Transport Media
  • Control Reagents
  • 6.6. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermal Cyclers
  • Automated Analyzers
  • Nucleic Acid Extractors
  • Fluorescence Readers

7. Human Metapneumovirus Diagnostics Market Regional And Country Analysis

  • 7.1. Global Human Metapneumovirus Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Human Metapneumovirus Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Metapneumovirus Diagnostics Market

  • 8.1. Asia-Pacific Human Metapneumovirus Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Metapneumovirus Diagnostics Market

  • 9.1. China Human Metapneumovirus Diagnostics Market Overview
  • 9.2. China Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Metapneumovirus Diagnostics Market

  • 10.1. India Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Metapneumovirus Diagnostics Market

  • 11.1. Japan Human Metapneumovirus Diagnostics Market Overview
  • 11.2. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Metapneumovirus Diagnostics Market

  • 12.1. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Metapneumovirus Diagnostics Market

  • 13.1. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Metapneumovirus Diagnostics Market

  • 14.1. South Korea Human Metapneumovirus Diagnostics Market Overview
  • 14.2. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Metapneumovirus Diagnostics Market

  • 15.1. Western Europe Human Metapneumovirus Diagnostics Market Overview
  • 15.2. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Metapneumovirus Diagnostics Market

  • 16.1. UK Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Metapneumovirus Diagnostics Market

  • 17.1. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Metapneumovirus Diagnostics Market

  • 18.1. France Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Metapneumovirus Diagnostics Market

  • 19.1. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Metapneumovirus Diagnostics Market

  • 20.1. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Metapneumovirus Diagnostics Market

  • 21.1. Eastern Europe Human Metapneumovirus Diagnostics Market Overview
  • 21.2. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Metapneumovirus Diagnostics Market

  • 22.1. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Metapneumovirus Diagnostics Market

  • 23.1. North America Human Metapneumovirus Diagnostics Market Overview
  • 23.2. North America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Metapneumovirus Diagnostics Market

  • 24.1. USA Human Metapneumovirus Diagnostics Market Overview
  • 24.2. USA Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Metapneumovirus Diagnostics Market

  • 25.1. Canada Human Metapneumovirus Diagnostics Market Overview
  • 25.2. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Metapneumovirus Diagnostics Market

  • 26.1. South America Human Metapneumovirus Diagnostics Market Overview
  • 26.2. South America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Metapneumovirus Diagnostics Market

  • 27.1. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Metapneumovirus Diagnostics Market

  • 28.1. Middle East Human Metapneumovirus Diagnostics Market Overview
  • 28.2. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Metapneumovirus Diagnostics Market

  • 29.1. Africa Human Metapneumovirus Diagnostics Market Overview
  • 29.2. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Metapneumovirus Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Human Metapneumovirus Diagnostics Market Competitive Landscape
  • 30.2. Human Metapneumovirus Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Metapneumovirus Diagnostics Market Other Major And Innovative Companies

  • 31.1. QuidelOrtho Corporation
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. ARUP Laboratories
  • 31.4. Qiagen NV
  • 31.5. Diasorin
  • 31.6. Luminex Corporation
  • 31.7. bioMerieux
  • 31.8. Seegene Inc.
  • 31.9. Cepheid
  • 31.10. R-Biopharm AG
  • 31.11. Certest Biotec
  • 31.12. ZeptoMetrix
  • 31.13. Xi'an Tianlong Science and Technology Co. Ltd
  • 31.14. The Native Antigen Company
  • 31.15. Hangzhou Testsea Biotechnology Co. Ltd.

32. Global Human Metapneumovirus Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Metapneumovirus Diagnostics Market

34. Recent Developments In The Human Metapneumovirus Diagnostics Market

35. Human Metapneumovirus Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Human Metapneumovirus Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Human Metapneumovirus Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Human Metapneumovirus Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer